Written by: Grace
The vaccine competition in Europe is getting more and more intense. According to an Oct. 8 report made by Medical Xpress, on Friday, Iceland announced a moratorium on the use of Moderna’s anti-CCP virus (Covid-19) vaccine, citing a slight increase in the risk of heart inflammation after receiving the Moderna shot.
Iceland’s measure against Moderna jabs appears to be more severe than those of its Nordic neighbors Switzerland, Norway, Denmark, and Finland, all of which have only restricted the use of the Moderna vaccine.
Denmark and Norway have officially recommended against the use of the Moderna vaccine for people under the age of 18. Since Thursday, Sweden and Finland have also suspended the use of the Moderna vaccine for people under 30 years old.
These countries are restricting the use of the Moderna vaccine because of the risk of inflammation of the myocardium (heart muscle) and pericardium (the membrane covering the heart). However, at the same time, they are recommending their residents to receive the Pfizer vaccine.
A statement published on the website of Iceland’s Health Directorate said, ” As the supply of Pfizer vaccine is sufficient in the territory … the chief epidemiologist has decided not to use the Moderna vaccine in Iceland.”
But the chief epidemiologist clearly indicated in a statement that “the increased incidence of myocarditis and pericarditis after vaccination with the Moderna vaccine, as well as with vaccination using Pfizer/BioNTech.”
For the past two months, Icelanders have been receiving the Janssen vaccine, a single-dose serum sold by the U.S. company Johnson & Johnson, while the elderly and immunocompromised people have been “almost exclusively” using the Moderna vaccine.
Iceland has about 370,000 residents, and 88 percent of the island’s population over the age of 12 is fully vaccinated.